Search Medical Condition
Please enter condition
Please choose location from dropdown

Diabetic Neuropathy Clinical Trials

A listing of Diabetic Neuropathy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (67) clinical trials

Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)

The purpose of this study is to evaluate safety and efficacy of EMA401 compared to placebo in patients with painful diabetic neuropathy (PDN).


A Real World Observational Registry of Chronic Wounds and Ulcers

This is a longitudinal, observational study of chronic wounds and ulcers treated at participating hospital based, outpatient wound centers. Data collection began in 2005. Structured data are collected at the point of care in the patient electronic health record and data from all patients at more than 100 wound centers ...

Phase N/A

Graded Exposure in Patients With Painful Diabetic Neuropathy

Intervention: Graded Exposure in vivo (GEXP) is a second-generation cognitive-behavioural intervention, and is characterized by systematic and repeated exposure to feared movements, activities and/or sensations in order to decrease fear and subsequently increase physical activity. Main study parameters/endpoints: The purpose of this project is to develop and test a cognitive ...

Phase N/A

Lidocaine for Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathy [DPN] is caused by diabetes-related metabolic damage to the sensory nervous system. It affects more than 3 million Americans and is leading cause of nerve damage-associated pain worldwide. Currently approved drugs such as gabapentin, pregabalin, and duloxetine provide pain relief only in 1 out of 4 or ...

Phase N/A

DECODING Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)

The prevalence of diabetes mellitus (DM) is very high in Spain, being nearly 14% according to oral glucose tolerance test (OGTT) results . The management of DM requires a significant consumption of healthcare resources, mainly in relation to the care of vascular complications. Among the late microvascular events which may ...

Phase N/A

Activity for Diabetic Polyneuropathy

Type 2 diabetes (T2D) affects over 8% of Americans, and half will develop peripheral neuropathy, a progressive injury to the very longest nerves of the body. Our previous research has found that neuropathy can be detected early in its course and followed by examining nerves that reach to the skin ...

Phase N/A

The Effects of Passive Vibration in Patients With Diabetic Peripheral Neuropathy

The study involves the following: Visit 1: Particpant's age, height, gender, and weight will be collected. Participant will fill out a questionnaire to assess participant's nerve function. This process will take approximately 2.5 minutes. Investigator will measure participant's balance, sensation, and skin blood flow (SBF). After completing the tests, participant ...

Phase N/A

Pressure-Sensing Insoles in the Neuropathic Ulcer Treatment Pathway

Pressure offloading is the lynchpin of neuropathic ulcer care. Multiple methods of statically reducing pressure have been employed, with various degrees of success, in the ulcer care continuum. Traditional offloading interventions redistribute the load on the plantar surface, and include: non-removable devices (total contact casts, removable walkers rendered non-removable, and ...

Phase N/A

Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy

Part A of this trial is a multi-center, prospective, double-blinded, sham-controlled, randomized clinical trial conducted on subjects with painful diabetic distal symmetric peripheral neuropathy. Part B of this trial is a 2-month single-arm, open-label, active treatment extension period upon completion of Part A. Eligible subjects will include those between 22 ...

Phase N/A

The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes

The investigators propose to examine the effects of GLP-1 receptor agonist Liraglutide on autonomic sudomotor function and endothelial and neurovascular functions as well as markers of inflammation in patients with type 2 diabetes mellitus (T2DM). The primary objective will be changes in peripheral autonomic function using sudorimetry (Sudoscan) after 1 ...